SCHEMBL12839243

SCHEMBL12839243

Nc1ccc(-c2cnc(NC(=O)CCc3ccccc3)c(CCc3ccccc3)n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 1/20 0.45
HCAR2 Q8TDS4 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C8 P10632 1/20 0.43
LMNA P02545 2/20 0.43
TSHR P16473 2/20 0.43
MAPT P10636 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HTT P42858 1/20 0.43
GHSR Q92847 1/20 0.42
WNT1 P04628 1/20 0.42
GSK3B P49841 1/20 0.42
DYRK1A Q13627 1/20 0.42
PLAU P00749 1/20 0.42
KMT2A Q03164 2/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
IKBKB O14920 1/20 0.41
NPC1 O15118 1/20 0.41
NFKB1 P19838 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12839226 0.94 ALDH1A1 (0.46) KMT2AADORA2AIKBKBNPC1RAB9A
SCHEMBL12839026 0.93 MCHR1 (0.47) ROCK2HCAR2CYP2C9CYP2C8LMNA
SCHEMBL12839207 0.92 ROCK2 (0.44) ROCK2HCAR2CYP2C9CYP2C8LMNA
SCHEMBL12839935 0.92 ADORA3 (0.48) ROCK2HCAR2CYP2C9CYP2C8LMNA
SCHEMBL12839214 0.91 TMIGD3 (0.45) TSHRGHSRKMT2AIKBKBNPC1
SCHEMBL12838878 0.90 HCAR2 (0.52) ROCK2HCAR2CYP2C9CYP2C8LMNA
SCHEMBL12839673 0.89 RAB9A (0.43) ROCK2HCAR2CYP2C9CYP2C8LMNA
SCHEMBL12839237 0.88 ATR (0.44) LMNAMAPTKMT2AIKBKBNPC1
SCHEMBL12839258 0.87 ADORA1 (0.46) MAPTHTTGHSRKMT2AADORA3
SCHEMBL12839051 0.87 RAB9A (0.46) ROCK2HCAR2CYP2C9CYP2C8LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110070656-A1 Fluorescent Proteins JNC CORPORATION (JP) 2011-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110070656-A1 Fluorescent Proteins CACYBP, CHLSN, LCP2 ROCK2 4744/4885HCAR2 3839/4885CYP2C9 3809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.